Trial Profile
Randomized phase II study of adjuvant chemotherapy with cisplatin + vinorelbine vs gemcitabine + vinorelbine in stage IB-IIIA radically resected non-small cell lung cancer (NSCLC) patients.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Nov 2012
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Vinorelbine (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Biomarker; Therapeutic Use
- Acronyms MADS
- 29 Jul 2011 New trial record